A tumor-penetrating polyamidoamine (PAMAM)-based nanoparticle (SPN@Pro-Gem) enables size-shrinkage in acidic conditions, facilitating deep gemcitabine delivery in pancreatic tumors while reducing immunosuppressive cells and upregulating PD-L1, thereby enhancing CTL infiltration [63]. The gene discussed is CD274; the disease is neoplasm.